| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Wang,Ling-Mei | Chairman | 1.33% | |
| Ye,Zhi-Hong | Director | 4.29% | NULIV HOLDING INC. |
| Jiang,Zheng-Qi | Director | 2.83% | GIDDI PHARMA CO., LTD. |
| Lin,Hong-Sheng | Director | 2.14% | CHANG SHYANG ENTERPRISE CO., LTD. |
| Ding,Ke-Hua | Independent Director | 0.00% | |
| Ma,Hai-Yi | Independent Director | 0.00% | |
| Huang,Bei-Bei | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 0 | 941 | 636 |
| Operating cost | 3,804 | 1,977 | 9,566 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | -3,804 | -1,036 | -8,930 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | -3,804 | -1,036 | -8,930 |
| Operating expenses | 81,981 | 130,423 | 89,282 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -85,785 | -131,459 | -98,212 |
| Non-operating income and expenses | 2,182 | 2,230 | 12,738 |
| Net profit (loss) before tax | -83,603 | -129,229 | -85,474 |
| Income tax expense (benefits) | 0 | 0 | 0 |
| Net profit (loss) of ongoing business for the current period | -83,603 | -129,229 | -85,474 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -83,603 | -129,229 | -85,474 |
| Other comprehensive profit (loss), net | 355 | -161 | 2 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -83,248 | -129,390 | -85,472 |
| Net profit (loss) attributable to owners of parent company | -83,603 | -129,229 | -85,474 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | -83,248 | -129,390 | -85,472 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | -1 | -2 | -1 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -79,645 | -114,808 | -69,201 |
| Net cash inflows (outflows) from investing activities | -49,311 | -28,558 | -2,502 |
| Net cash inflow (outflow) from financing activities | -5,231 | 441,954 | -5,428 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 355 | -161 | 2 |
| Increase (decrease) in cash and cash equivalents in the current period | -133,832 | 298,427 | -77,129 |
| Beginning balance of cash and cash equivalents | 451,858 | 153,431 | 230,560 |
| Ending balance of cash and cash equivalents | 318,026 | 451,858 | 153,431 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 338,186 | 466,458 | 161,148 |
| Non-current asset | 167,163 | 127,418 | 74,502 |
| Total asset | 505,349 | 593,876 | 235,650 |
| Current liability | 26,913 | 38,661 | 24,116 |
| Non-current liability | 56,203 | 62,228 | 47,996 |
| Total liability | 83,116 | 100,889 | 72,112 |
| share capital | 558,381 | 557,951 | 446,965 |
| Equity - secruity token | - | - | - |
| capital reserve | 602,558 | 590,494 | 242,641 |
| retained earning | -739,128 | -655,525 | -526,296 |
| Other equity | 422 | 67 | 228 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 422,233 | 492,987 | 163,538 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 422,233 | 492,987 | 163,538 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 168 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 7 | 8 | 3 |
